Health
Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence – News-Medical.Net
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone…
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The study, published in Blood Advances,…
Continue Reading
